Sang‐Hyun Ihm

ORCID: 0000-0001-5017-5421
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Blood Pressure and Hypertension Studies
  • Heart Rate Variability and Autonomic Control
  • Cardiovascular Function and Risk Factors
  • Hormonal Regulation and Hypertension
  • Cardiovascular Health and Disease Prevention
  • Cardiac Imaging and Diagnostics
  • Cardiovascular Disease and Adiposity
  • Sodium Intake and Health
  • Nutritional Studies and Diet
  • Health and Wellbeing Research
  • Heart Failure Treatment and Management
  • Atherosclerosis and Cardiovascular Diseases
  • Lipoproteins and Cardiovascular Health
  • Diabetes Treatment and Management
  • Medication Adherence and Compliance
  • Cardiac Arrhythmias and Treatments
  • Cardiac Fibrosis and Remodeling
  • Atrial Fibrillation Management and Outcomes
  • Coronary Interventions and Diagnostics
  • Cardiac pacing and defibrillation studies
  • Cardiovascular Health and Risk Factors
  • Cardiovascular and exercise physiology
  • Peptidase Inhibition and Analysis
  • Cardiac electrophysiology and arrhythmias
  • Cardiovascular Syncope and Autonomic Disorders

Catholic University of Korea
2016-2025

Bucheon St. Mary's Hospital
2016-2025

Korean Society of Hypertension
2021-2022

Seoul St. Mary's Hospital
2000-2016

Dongguk University Ilsan Hospital
2016

Seoul National University Hospital
2016

National Taiwan University Hospital
2016

St. Vincent's Hospital
2016

Hallym University
2016

Bioengineering Center
2014

The standardized techniques of blood pressure (BP) measurement in the clinic are emphasized and it is recommended to replace mercury sphygmomanometer by a non-mercury sphygmomanometer. Out-of-office BP using home monitoring (HBPM) or ambulatory (ABPM) even automated office (AOBP) correctly measure patient’s genuine BP. Hypertension (HTN) treatment should be individualized based on cardiovascular (CV) risk level Based recent clinical study data proving benefits intensive lowering high...

10.1186/s40885-019-0124-x article EN cc-by Clinical Hypertension 2019-08-01

The Korean Society of Hypertension has published the Korea Fact Sheet 2020 to provide an overview magnitude and management status hypertension their recent trends.

10.1186/s40885-021-00166-2 article EN cc-by Clinical Hypertension 2021-03-15

Abstract Background The Korea Hypertension Fact Sheet 2023, presented by the Korean Society of Hypertension, offers an overview prevalence and management hypertension, along with recent trends. Methods Data for were derived from National Health Nutrition Examination Survey spanning 1998 to 2021, Insurance Big 2002 2021. Results As hypertension affected 28.0% adults aged 20 older, totaling approximately 12.3 million individuals, 5.3 (43.5%) 65 or older. Among those awareness stood at 74.1%,...

10.1186/s40885-024-00262-z article EN cc-by Clinical Hypertension 2024-03-01

Salt-sensitive hypertension (SSH) is characterized by impaired sodium excretion and subnormal vasodilatory response to salt loading. Sacubitril/valsartan (LCZ696) was hypothesized increase natriuresis diuresis result in superior blood pressure control compared with valsartan Asian patients SSH. In this randomized, double-blind, crossover study, 72 SSH received sacubitril/valsartan 400 mg 320 once daily for 4 weeks each. diagnosed if the mean arterial increased ≥10% when switched from low (50...

10.1161/hypertensionaha.116.08484 article EN Hypertension 2016-11-15

The Korean Society of Hypertension guideline defines hypertension as systolic blood pressure ≥ 140 mmHg or diastolic 90 mmHg, where the effectiveness pharmacological treatment has been established. It is confirmed that higher levels are associated with increased risk cardiovascular disease and mortality also in population. About one third adults aged 30 years older estimated to have hypertension, prevalence gradually increases age increases. awareness, treatment, control rates generally...

10.1186/s40885-019-0121-0 article EN cc-by Clinical Hypertension 2019-08-01

The Korean Society of Hypertension has published the Korea Fact Sheet 2021 to provide an overview magnitude and management status hypertension their recent trends.The Sheets were based on analyses adults aged 20 years or older 1998-2019 National Health Nutrition Examination Survey 2002-2019 Insurance Big Data.Currently, population average systolic/diastolic blood pressure was 119/76 mmHg in showing little change decade. It is estimated that 28% adult (33% 30 older) have hypertension. number...

10.1186/s40885-021-00188-w article EN cc-by Clinical Hypertension 2022-01-03

We examined the role that enzymatic protein O-GlcNAcylation plays in development of diabetic cardiomyopathy a mouse model Type 2 diabetes mellitus (DM2). Mice injected with low-dose streptozotocin and fed high-fat diet developed mild hyperglycemia obesity consistent DM2. Studies were performed from 1 to 6 mo after initiating DM2 protocol. After mo, mice showed increased body weight, impaired fasting blood glucose, hyperinsulinemia. Echocardiographic evaluation revealed left ventricular...

10.1152/ajpregu.00548.2011 article EN AJP Regulatory Integrative and Comparative Physiology 2012-08-09

Excess enzyme-mediated protein O-GlcNAcylation is known to occur with diabetes mellitus. A characteristic of diabetic cardiomyopathy the development myocardial fibrosis. The role that enhanced plays in modulating phenotype cardiac fibroblasts (CF) unknown. To address this issue, rat CF were cultured normal glucose (NG; 5 mM glucose) or high-glucose (HG; 25 mM) media for 48 h. Results demonstrate HG have higher levels (∼50%) overall vs. NG cells. Key regulators collagen synthesis such as...

10.1152/ajpcell.00251.2013 article EN AJP Cell Physiology 2014-02-20

Abstract Smartphone technology has spread rapidly around the globe. According to a report released by Korea Information Society Development Institute, about 95% of Koreans aged more than 30 years old owned smartphones. Recently, blood pressure (BP) measurement using photoplethysmography-based smartphone algorithm paired with smartwatch is continuously evolving. In this document, Korean Hypertension intends remark current results / smartwatch-based BP and recommend optimal methods device. We...

10.1186/s40885-020-00158-8 article EN cc-by Clinical Hypertension 2021-01-25

The prevention of subsequent cardiovascular disease (CVD) is an essential part cancer survivorship care. We conducted the present study to investigate association between TyG index (a surrogate marker insulin resistance) and risk events in survivors.Adult patients, who underwent routine health examinations during 2009-2010 were survived for more than 5 years as January 1, 2011, followed hospitalization CVD (either ischemic heart disease, stroke, or failure) until December 2020. Cox model was...

10.1186/s12933-022-01490-z article EN cc-by Cardiovascular Diabetology 2022-04-16

Background— Limited availability of noninvasive and biologically precise diagnostic tools poses a challenge for the evaluation management patients with myocarditis. Methods Results— The feasibility cardiovascular magnetic resonance (CMR) imaging magneto-fluorescent nanoparticles (MNPs) detection myocarditis its effectiveness in discriminating inflammation grades were assessed experimental autoimmune (EAM) (n=65) control (n=10) rats. After undergoing CMR, rats administered MNPs, followed by...

10.1161/circulationaha.111.075283 article EN Circulation 2012-05-02

Treatment of hypertension improves cardiovascular, renal, and cerebrovascular outcomes. However, the benefit treatment may be different according to patients' characteristics. Additionally, target blood pressure or initial drug choice should customized special conditions hypertensive patients. In this part III, we reviewed previous data presented recommendations for some populations such as diabetes mellitus, chronic kidney disease, elderly people, cardio-cerebrovascular disease.

10.1186/s40885-019-0123-y article EN cc-by Clinical Hypertension 2019-08-01

With the recent obesity pandemic, obesity-related hypertension and its complications (e.g., heart failure, coronary disease, chronic kidney disease [CKD]) are gaining attention in clinical research fields. Obesity-related frequently precedes onset of CKD aggravates progression. In this review, we discuss role visceral fat pathophysiology potential therapeutic strategies for prevention management. Various factors, including sympathetic nervous system, renin-angiotensin-aldosterone...

10.23876/j.krcp.23.072 article EN cc-by-nc-nd Kidney Research and Clinical Practice 2023-07-28

Cancer survivors increasingly face cardiovascular disease (CVD), with diabetes as a major risk factor. This study investigates the relationship between adherence to antidiabetic medications and (CV) outcomes in cancer patients. Using data from Korean National Health Insurance Service-National Sample Cohort, we assessed clinical of adult patients prescribed medications. The population was categorized based on medication adherence, determined by possession ratio (MPR): good (MPR ≥ 0.8),...

10.3390/cancers17071117 article EN Cancers 2025-03-26
Coming Soon ...